Skip to main content
Clinical Trials/NCT01250301
NCT01250301CompletedNot Applicable

Complementing Current NHS Stop Smoking Service Treatments for Smokers With Behavioural Replacement: The Role of De-nicotinised Cigarettes

Queen Mary University of London1 site in 1 country200 target enrollmentStarted: July 1, 2011Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
200
Locations
1
Primary Endpoint
Urges to smoke in first week of abstinence

Study Overview

Brief Summary

The aim of this study is to determine if using a behavioural replacement for smoking (de-nicotinised cigarettes; DNCs), in addition to standard treatment during the first two weeks after the target quit date, can reduce urges to smoke over the first 4-weeks of abstinence. Two hundred smokers who want to quit will be recruited from the community. They would all receive standard smoking cessation treatment from the NHS Stop Smoking Service (NHS SSS), which uses a combination of stop smoking medication (e.g. nicotine replacement therapy, Champix) and motivational support. On their target quit date, participants would be randomised to receive behavioural replacement ( i.e. use of de-nicotinised cigarettes) plus standard treatment for the first two weeks of their quit attempt, or to continue with standard treatment alone. De-nicotinised cigarettes are similar to standard cigarettes except that they do not deliver nicotine to the smoker. Participants will rate their urges to smoke at each week. Standard NHS SSS measures will also be taken in addition to user acceptability ratings and reactions to smoking cues.

The hypothesis is that complementing current NHS SSS treatments with de-nicotinised cigarettes, to address the non-nicotine factors associated with smoking and to help extinguish smoking behaviour, would result in lower urges to smoke than standard treatment alone.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •18 years or over
  • •Seeking treatment to stop smoking

Exclusion Criteria

  • •Pregnant or breastfeeding
  • •Acute psychiatric illness

Arms & Interventions

De-nicotinised cigarettes + standard treatment

Experimental

Intervention: De-nicotinised cigarettes + standard treatment (Other)

Standard treatment

Active Comparator

Intervention: Standard Treatment (Other)

Outcomes

Primary Outcomes

Urges to smoke in first week of abstinence

Time Frame: 1 week

Differences in urges to smoke in the first week of abstinence between participants who receive a behavioural replacement (DNCs) plus standard NHS SSS treatment, with those who receive standard NHS SSS treatment alone, will be measured by the Mood and Physical Symptoms Scale (MPSS; West \& Hajek, 2004).

Secondary Outcomes

  • Change in ratings of tobacco withdrawal symptoms, measured by the MPSS(First 4 weeks of abstinence (from baseline- 4 weeks post-quit))
  • CO-validated continuous abstinence rates(4-weeks)
  • Acceptability and user reactions to DNCs(2 weeks)
  • Urges to smoke 24 hours after quitting, measured by the MPSS(24 hours)
  • Profile of adverse effects up to 12 weeks post quitting(12 weeks)
  • Reactions to smoking cues(12 weeks)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Hayden McRobbie

Dr. Hayden McRobbie

Queen Mary University of London

Study Sites (1)

Loading locations...

Similar Trials